Second-line chemotherapy in small cell lung cancer in a modified administration of topotecan combined with paclitaxel : a phase II study
- Author
- STATHOPOULOS, G. P1 ; CHRISTODOULOU, Ch2 ; DIMITROULIS, J4 ; GEORGATOU, N4 ; KATIS, K4 ; STATHOPOULOS, J1 ; SKARLOS, D2 ; RIGATOS, S. K3 ; GIANNAKAKIS, Th3 ; ARMENAKI, O4 ; ANTONIOU, D4 ; ATHANASIADIS, A5 ; GIAMBOUDAKIS, P4
[1] Department of Oncology, Errikos Dunant Hospital, Semitelou 2A, 115 28 Athens, Greece
[2] Department of Oncology, Errikos Dunant Hospital, Athens, Greece
[3] Ag. Anargyri Hospital, Athens, Greece
[4] SOLCA Oncology Group, Sotiria Hospital, Athens, Greece
[5] Oncology Department, Larissa, Greece - Source
Cancer chemotherapy and pharmacology. 2006, Vol 57, Num 6, pp 796-800, 5 p ; ref : 28 ref
- CODEN
- CCPHDZ
- ISSN
- 0344-5704
- Scientific domain
- Medical oncology; Pharmacology drugs
- Publisher
- Springer, Berlin
- Publication country
- Germany
- Document type
- Article
- Language
- English
- Author keyword
- Paclitaxel SCLC Topotecan Weekly administration
- Keyword (fr)
- Anticancéreux Cancer du poumon Carcinome petite cellule bronchopulmonaire Chimiothérapie Essai clinique phase II Homme Paclitaxel Topotécane Traitement Camptothécine dérivé Inhibiteur topoisomerase I Pyrano indolizino quinoléine dérivé Antimitotique Appareil respiratoire pathologie Bronche pathologie DNA topoisomerase Enzyme Inhibiteur enzyme Isomerases Poumon pathologie Taxane dérivé Tumeur maligne
- Keyword (en)
- Antineoplastic agent Lung cancer Bonchopulmonary small cell carcinoma Chemotherapy Phase II trial Human Paclitaxel Topotecan Treatment Antimitotic Respiratory disease Bronchus disease DNA topoisomerase Enzyme Enzyme inhibitor Isomerases Lung disease Taxane derivatives Malignant tumor
- Keyword (es)
- Anticanceroso Cáncer del pulmón Carcinoma pequeňa célula bronchopulmonar Quimioterapia Ensayo clínico fase II Hombre Paclitaxel Topotecán Tratamiento Antimitótico Aparato respiratorio patología Bronquio patología DNA topoisomerase Enzima Inhibidor enzima Isomerases Pulmón patología Taxane derivado Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B11 Pneumology / 002B11A Tumors of the respiratory system and mediastinum
- Discipline
- Pharmacological treatments Pulmonology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 17729142
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1007/s00280-005-0085-5 
https://dx.doi.org/10.1007/s00280-005-0085-5
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00280-005-0085-5\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:136:\"Second-line chemotherapy in small cell lung cancer in a modified administration of topotecan combined with paclitaxel : a phase II study\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Cancer chemotherapy and pharmacology\";s:9:\"\u0000*\u0000stitle\";s:27:\"Cancer chemother. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"57\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"796\";s:8:\"\u0000*\u0000epage\";s:3:\"800\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0344-5704\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:12:\"STATHOPOULOS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"G. P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:17:\"CHRISTODOULOU, Ch\";i:1;s:14:\"DIMITROULIS, J\";i:2;s:12:\"GEORGATOU, N\";i:3;s:8:\"KATIS, K\";i:4;s:15:\"STATHOPOULOS, J\";i:5;s:10:\"SKARLOS, D\";i:6;s:13:\"RIGATOS, S. K\";i:7;s:15:\"GIANNAKAKIS, Th\";i:8;s:11:\"ARMENAKI, O\";i:9;s:11:\"ANTONIOU, D\";i:10;s:15:\"ATHANASIADIS, A\";i:11;s:15:\"GIAMBOUDAKIS, P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CCPHDZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:136:\"Second-line chemotherapy in small cell lung cancer in a modified administration of topotecan combined with paclitaxel : a phase II study\";s:8:\"\u0000*\u0000place\";s:6:\"Berlin\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00280-005-0085-5\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:136:\"Second-line chemotherapy in small cell lung cancer in a modified administration of topotecan combined with paclitaxel : a phase II study\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Cancer chemotherapy and pharmacology\";s:9:\"\u0000*\u0000stitle\";s:27:\"Cancer chemother. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"57\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"796\";s:8:\"\u0000*\u0000epage\";s:3:\"800\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0344-5704\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:12:\"STATHOPOULOS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"G. P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:17:\"CHRISTODOULOU, Ch\";i:1;s:14:\"DIMITROULIS, J\";i:2;s:12:\"GEORGATOU, N\";i:3;s:8:\"KATIS, K\";i:4;s:15:\"STATHOPOULOS, J\";i:5;s:10:\"SKARLOS, D\";i:6;s:13:\"RIGATOS, S. K\";i:7;s:15:\"GIANNAKAKIS, Th\";i:8;s:11:\"ARMENAKI, O\";i:9;s:11:\"ANTONIOU, D\";i:10;s:15:\"ATHANASIADIS, A\";i:11;s:15:\"GIAMBOUDAKIS, P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CCPHDZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:136:\"Second-line chemotherapy in small cell lung cancer in a modified administration of topotecan combined with paclitaxel : a phase II study\";s:8:\"\u0000*\u0000place\";s:6:\"Berlin\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00280-005-0085-5\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00280-005-0085-5\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:136:\"Second-line chemotherapy in small cell lung cancer in a modified administration of topotecan combined with paclitaxel : a phase II study\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Cancer chemotherapy and pharmacology\";s:9:\"\u0000*\u0000stitle\";s:27:\"Cancer chemother. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"57\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"796\";s:8:\"\u0000*\u0000epage\";s:3:\"800\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0344-5704\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:12:\"STATHOPOULOS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"G. P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:17:\"CHRISTODOULOU, Ch\";i:1;s:14:\"DIMITROULIS, J\";i:2;s:12:\"GEORGATOU, N\";i:3;s:8:\"KATIS, K\";i:4;s:15:\"STATHOPOULOS, J\";i:5;s:10:\"SKARLOS, D\";i:6;s:13:\"RIGATOS, S. K\";i:7;s:15:\"GIANNAKAKIS, Th\";i:8;s:11:\"ARMENAKI, O\";i:9;s:11:\"ANTONIOU, D\";i:10;s:15:\"ATHANASIADIS, A\";i:11;s:15:\"GIAMBOUDAKIS, P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CCPHDZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:136:\"Second-line chemotherapy in small cell lung cancer in a modified administration of topotecan combined with paclitaxel : a phase II study\";s:8:\"\u0000*\u0000place\";s:6:\"Berlin\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00280-005-0085-5\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:136:\"Second-line chemotherapy in small cell lung cancer in a modified administration of topotecan combined with paclitaxel : a phase II study\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Cancer chemotherapy and pharmacology\";s:9:\"\u0000*\u0000stitle\";s:27:\"Cancer chemother. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"57\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"796\";s:8:\"\u0000*\u0000epage\";s:3:\"800\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0344-5704\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:12:\"STATHOPOULOS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"G. P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:17:\"CHRISTODOULOU, Ch\";i:1;s:14:\"DIMITROULIS, J\";i:2;s:12:\"GEORGATOU, N\";i:3;s:8:\"KATIS, K\";i:4;s:15:\"STATHOPOULOS, J\";i:5;s:10:\"SKARLOS, D\";i:6;s:13:\"RIGATOS, S. K\";i:7;s:15:\"GIANNAKAKIS, Th\";i:8;s:11:\"ARMENAKI, O\";i:9;s:11:\"ANTONIOU, D\";i:10;s:15:\"ATHANASIADIS, A\";i:11;s:15:\"GIAMBOUDAKIS, P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CCPHDZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:136:\"Second-line chemotherapy in small cell lung cancer in a modified administration of topotecan combined with paclitaxel : a phase II study\";s:8:\"\u0000*\u0000place\";s:6:\"Berlin\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00280-005-0085-5\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:136:\"Second-line chemotherapy in small cell lung cancer in a modified administration of topotecan combined with paclitaxel : a phase II study\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Cancer chemotherapy and pharmacology\";s:9:\"\u0000*\u0000stitle\";s:27:\"Cancer chemother. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"57\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"796\";s:8:\"\u0000*\u0000epage\";s:3:\"800\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0344-5704\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:12:\"STATHOPOULOS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"G. P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:17:\"CHRISTODOULOU, Ch\";i:1;s:14:\"DIMITROULIS, J\";i:2;s:12:\"GEORGATOU, N\";i:3;s:8:\"KATIS, K\";i:4;s:15:\"STATHOPOULOS, J\";i:5;s:10:\"SKARLOS, D\";i:6;s:13:\"RIGATOS, S. K\";i:7;s:15:\"GIANNAKAKIS, Th\";i:8;s:11:\"ARMENAKI, O\";i:9;s:11:\"ANTONIOU, D\";i:10;s:15:\"ATHANASIADIS, A\";i:11;s:15:\"GIAMBOUDAKIS, P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CCPHDZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:136:\"Second-line chemotherapy in small cell lung cancer in a modified administration of topotecan combined with paclitaxel : a phase II study\";s:8:\"\u0000*\u0000place\";s:6:\"Berlin\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
